{"id":"W3031215633","doi":"10.1200/jco.2020.38.15_suppl.11505","title":"Preliminary results of a phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Response Evaluation Criteria in Solid Tumors; Internal medicine; Progressive disease; Clinical endpoint; Oncology; Sarcoma; Neoadjuvant therapy; Cohort; Pathology; Cancer; Randomized controlled trial; Chemotherapy; Immunotherapy; Breast cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003562809,0.0009600076,0.001282903,0.0003048376,0.0003176014,0.000701775,0.0006028661,0.000793181,0.002529051],"category_scores_gemma":[0.001938626,0.0003948518,0.00101043,0.0003025272,0.0007412879,0.0006034036,0.0003654782,0.001780096,0.0004978311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006783214,"about_ca_system_score_gemma":0.001233292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000711553,"about_ca_topic_score_gemma":0.002184527,"domain_scores_codex":[0.9990019,0.0006114509,0.00007786261,0.0001064226,0.00007749103,0.0001247827],"domain_scores_gemma":[0.9983643,0.0004154055,0.0002827294,0.000143047,0.0001114172,0.0006831076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7471418,0.09145544,0.02459712,0.0008200665,0.001891572,0.0003420139,0.0003384396,0.002036969,0.05186374,0.000191387,0.002921779,0.07639967],"study_design_scores_gemma":[0.2545849,0.701402,0.03473172,0.00003904962,0.0008671927,0.0003177413,0.00009636406,0.0009372092,0.004603816,0.0001427003,0.002256047,0.00002129523],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930695,0.001297478,0.000874229,0.0003126878,0.00009779631,0.002191779,0.001108498,0.00004167838,0.001006345],"genre_scores_gemma":[0.9893684,0.0007405289,0.002131457,0.0007046935,0.0001132613,0.002306406,0.003449278,0.00001640241,0.001169682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003562809,"threshold_uncertainty_score":0.01884216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1772293650814535,"score_gpt":0.444388128138905,"score_spread":0.2671587630574516,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}